References & Citations
Economics > General Economics
Title: Valuing Pharmaceutical Drug Innovations: An Event Study Approach
(Submitted on 14 Dec 2022 (this version), latest version 13 Apr 2024 (v4))
Abstract: We measure the $\textit{value of pharmaceutical drug innovations}$ by estimating the market values of drugs and their development costs. We rely on market responses to firms' drug development announcements to identify the values and costs. Using announcements by public U.S. pharmaceutical firms and their daily stock returns, we estimate the average market value of a successful drug at \$1.62 billion. At the discovery stage, drugs are valued at \$64.3 million, whereas their expected development cost is \$58.5 million, on average. Furthermore, we estimate the costs of the three phases of clinical trials at \$0.6, \$30, and \$41 million, respectively.
Submission history
From: Gaurab Aryal [view email][v1] Wed, 14 Dec 2022 18:09:32 GMT (1273kb)
[v2] Tue, 11 Apr 2023 16:41:13 GMT (944kb)
[v3] Wed, 15 Nov 2023 14:34:06 GMT (1332kb)
[v4] Sat, 13 Apr 2024 15:10:57 GMT (945kb)
Link back to: arXiv, form interface, contact.